MedTrace Logo

Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and Mexico

NCT02381210 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2019-02-08

No results posted yet for this study

Summary

A cross sectional study design will evaluate the diagnostic value of the CRD test to the pregnant women attending the Dhaka Medical College Hospital and Hospital Materno-Infantil Inguarán, tertiary level facilities in Bangladesh and Mexico City.

Conditions

Interventions

DEVICE

Congo Red Dot Test

The Congo Red Dot test is a simple test has been developed to detect unfolded or misfolded proteins in urine.

Sponsors & Collaborators

  • Nationwide Children's Hospital

    collaborator OTHER

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Irina Buhimschi, Dr · Nationwide Children's Hospital

  • Beverly Winikoff, Dr · Gynuity Health Projects

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-12-01
Completion
2018-12-30

Countries

  • Bangladesh
  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02381210 on ClinicalTrials.gov